Close Menu

FORCE

Genetic counselors and patient advocates say more people are refusing genetic testing because they're uncertain of how it will impact their insurance.

Women with a family history of breast and ovarian cancer who are interested in getting genetically tested to gauge whether they have a heightened risk for the diseases should speak to a genetic counselor before getting tested, patient groups are advising their members.

This article has been updated to correct that Ellen Matloff is a plaintiff in AMP v. USPTO.

At a SACGHS meeting last week, FORCE said that Myriad Genetics sales representatives discourage doctors from referring patients to genetic counselors, and recommended the committee make recommendations for greater monitoring of such actions. SACGHS plans to invite Myriad to respond to the allegations.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.